(Q47913342)

6 February 2018

title

Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma (English)

1 reference

6 February 2018

author name string

Lemieux B

1

1 reference

6 February 2018

Tartas S

2

1 reference

6 February 2018

Traulle C

3

1 reference

6 February 2018

Espinouse D

4

1 reference

6 February 2018

Thieblemont C

5

1 reference

6 February 2018

Bouafia F

6

1 reference

6 February 2018

Alhusein Q

7

1 reference

6 February 2018

Antal D

8

1 reference

6 February 2018

Salles G

9

1 reference

6 February 2018

Coiffier B

10

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 2004

1 reference

6 February 2018

Bone Marrow Transplantation

published in

1 reference

6 February 2018

volume

33

1 reference

6 February 2018

issue

9

1 reference

6 February 2018

page(s)

921-923

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704467

exact match

0 references

cites work

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704467

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704467

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704467

Autoimmune thrombocytopenic purpura after autologous stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704467

Neutropenia in patients treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704467

7 January 2021

Delayed-onset neutropenia associated with rituximab therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704467

7 January 2021

Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704467

7 January 2021

Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704467

7 January 2021

CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704467

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704467

1 reference

6 February 2018

1 reference

6 February 2018